These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 2692448

  • 21. [The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group].
    Hirao Y, Ozono S, Kagebayashi Y, Yoshi M, Tani Y, Uemura H, Momose H, Okajima E.
    Hinyokika Kiyo; 1996 Oct; 42(10):795-804. PubMed ID: 8951478
    [Abstract] [Full Text] [Related]

  • 22. The contemporary value of pretreatment prostatic acid phosphatase to predict pathological stage and recurrence in radical prostatectomy cases.
    Moul JW, Connelly RR, Perahia B, McLeod DG.
    J Urol; 1998 Mar; 159(3):935-40. PubMed ID: 9474187
    [Abstract] [Full Text] [Related]

  • 23. [Current assessment of radioimmunological determination (RIA) of prostate acid phosphatase in the diagnosis of prostatic cancer].
    Huber PR, Hagmaier V, Scholer A, Lyrer P, Christen P, Wolf T, Kanszo G, Hassel JP, Rutishauser G.
    Helv Chir Acta; 1981 Aug; 48(3-4):445-52. PubMed ID: 7287483
    [Abstract] [Full Text] [Related]

  • 24. [Immunological colorimetric determination of serum prostatic acid phosphatase activity in patients with prostatic diseases comparing with RIA and Kind-King modified methods].
    Hayashi Y, Saionji K, Kitagawa R, Iizuka K, Higurashi H.
    Rinsho Byori; 1985 Sep; 33(9):1031-40. PubMed ID: 3908752
    [No Abstract] [Full Text] [Related]

  • 25. Comparative study of biochemical technique and radioimmunoassay for the measurement of serum prostatic acid phosphatase. Interest in the diagnosis of prostatic cancer?
    Canal P, Soula G.
    Pathol Biol (Paris); 1982 Dec; 30(10):833-6. PubMed ID: 6185909
    [Abstract] [Full Text] [Related]

  • 26. [Clinical evaluation of serum gamma-seminoprotein in patients with prostatic cancer].
    Ishihara Y, Hiromoto Y, Higaki Y, Imamura K.
    Hinyokika Kiyo; 1989 Mar; 35(3):409-13. PubMed ID: 2660507
    [Abstract] [Full Text] [Related]

  • 27. [Measurement of serum PSA by DELFIA PSA kit and its application for mass screening. The Gunma Urological Oncology Study Group].
    Imai K, Watanabe K, Higashi H, Shinya H, Okamura K, Matsuo Y, Yazima H, Takezawa Y, Yamanaka H.
    Hinyokika Kiyo; 1993 Sep; 39(9):807-12. PubMed ID: 7692709
    [Abstract] [Full Text] [Related]

  • 28. Prostatic acid phosphatase: current concepts.
    Romas NA.
    Semin Urol; 1983 Aug; 1(3):177-85. PubMed ID: 6379804
    [Abstract] [Full Text] [Related]

  • 29. [Immunoenzyme assay for prostate-specific acid phosphatase in prostatic cancer].
    Bauer HW.
    Med Welt; 1982 Nov 19; 33(46):1616-21. PubMed ID: 6185820
    [No Abstract] [Full Text] [Related]

  • 30. [The diagnostic value of the radioimmunological estimation of prostatic acid phosphatase. Comparative value of the measurement of enzyme activity (author's transl)].
    Tellier JL, Chatal JF, Bourdin S, Auvigne J, Etienne P, Faye R.
    J Urol (Paris); 1981 Nov 19; 87(3):169-73. PubMed ID: 7240777
    [Abstract] [Full Text] [Related]

  • 31. The value of prostatic acid phosphatase and prostate specific antigen as serum markers in carcinoma of the prostate.
    Akdaş A, Simşek F, Ilker Y, Türkeri L, Ercan H.
    Int Urol Nephrol; 1993 Nov 19; 25(3):271-8. PubMed ID: 7693607
    [Abstract] [Full Text] [Related]

  • 32. [Clinical studies of gamma-seminoprotein in prostatic disease. I. Clinical evaluation of serum gamma-seminoprotein].
    Hasegawa S, Nakashima J, Nakashima Y, Nakamura S, Kimura S.
    Hinyokika Kiyo; 1987 Dec 19; 33(12):2055-8. PubMed ID: 3329453
    [Abstract] [Full Text] [Related]

  • 33. Multiple marker evaluation in human prostate cancer with the use of tissue-specific antigens.
    Kuriyama M, Wang MC, Lee CL, Killian CS, Papsidero LD, Inaji H, Loor RM, Lin MF, Nishiura T, Slack NH, Murphy GP, Chu TM.
    J Natl Cancer Inst; 1982 Jan 19; 68(1):99-105. PubMed ID: 6172628
    [Abstract] [Full Text] [Related]

  • 34. Free and total serum PSA values in patients with prostatic intraepithelial neoplasia (PIN), prostate cancer and BPH. Is F/T PSA a potential probe for dormant and manifest cancer?
    Tarle M, Kraljić I.
    Anticancer Res; 1997 Jan 19; 17(3A):1531-4. PubMed ID: 9179191
    [Abstract] [Full Text] [Related]

  • 35. [The significance of free-type PSA and complex-type PSA in patients with prostatic carcinoma--the characteristics of ACS-PSA method compared with that of Delfia- and Eiken-PSA method].
    Arai K, Honda M, Hosoya Y, Sumi S, Umeda H, Yoshida K.
    Rinsho Byori; 1996 Apr 19; 44(4):345-50. PubMed ID: 8847816
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Serum acid phosphatase determined by the radioimmunochemical method (P.A.P.-RIA): its diagnostic value in prostatic cancer].
    Marczyńska A, Kulpa J, Adamczyk B, Leńko J.
    Przegl Lek; 1982 Sep 19; 39(8):573-6. PubMed ID: 6182582
    [No Abstract] [Full Text] [Related]

  • 38. [Prostatic acid phosphatase measured by immunoenzyme assay].
    Fuse H, Zama S, Shimazaki J.
    Hinyokika Kiyo; 1985 Nov 19; 31(11):1957-64. PubMed ID: 2418660
    [Abstract] [Full Text] [Related]

  • 39. [Tests for prostate-derived enzymes. B. Immunochemical analysis of serum PAP and its clinical significance].
    Koiso K, Nemoto R, Ishikawa S, Uchida K.
    Rinsho Byori; 1986 Jul 19; 34 Spec No 68():42-9. PubMed ID: 3531635
    [No Abstract] [Full Text] [Related]

  • 40. Tumor markers. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.
    Stamey TA, Ekman PE, Blankenstein MA, Cooper EH, Kontturi M, Lilja H, Oesterling JE, Stenman UH, Turkes A.
    Scand J Urol Nephrol Suppl; 1994 Jul 19; 162():73-87; discussion 115-27. PubMed ID: 7529430
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.